Evidence map›Paper›PMID 41503135›Full record

ArticleAtherosclerosis plus2026

Chunxia Guo, Yudong Rao, Hao Zhou, Yiran Feng, Ganyu Deng, Lin Yang, Ying Zhang, Xueya Zhang

Abstract read
In one paragraph

Article in Atherosclerosis plus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Freeze-DriedBiomolecules · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chunxia GuoDepartment of Traditional Chinese Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, 650000, China.
Yudong RaoDepartment of Traditional Chinese Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, 650000, China.
Hao ZhouDepartment of Traditional Chinese Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, 650000, China.
Yiran FengDepartment of Traditional Chinese Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, 650000, China.
Ganyu DengDepartment of Traditional Chinese Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, 650000, China.
Lin YangDepartment of Traditional Chinese Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, 650000, China.
Ying ZhangDepartment of Traditional Chinese Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, 650000, China.
Xueya ZhangDepartment of Traditional Chinese Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, 650000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Leeches and other herbs may improve atherosclerosis symptoms. This study explores Methods: In vivo used high-fat diet + rabbit carotid balloon injury model, with Results: The in vivo findings indicated that P.manillensis is capable of lowering blood lipid levels and exhibiting anti-thrombotic properties. Additionally, P.manillensis significantly alleviated pathological damage and lipid deposition in the common carotid artery, and reduced apoptosis of the common carotid artery smooth muscle cells. Further assays revealed that P.manillensis markedly decreased the levels of PI3K, p-AKT, NF-κB p65, NLRP3, Caspase-1, eNOS, GSDMD, IL-1β, and IL-18. In vitro results demonstrated that serum containing P.manillensis significantly enhanced cell activity and ATP production while decreasing the apoptosis rate, IL-1β, IL-18, LDH, and ROS, PI3K, p-AKT, NF-κB p65, NLRP3, Caspase-1, GSDMD, and ASC levels. Conclusion: Both in vivo and in vitro studies have confirmed that P.manillensis ameliorates endothelial damage and inflammatory responses in AS, with involvement of the PI3K/AKT and NF-κB signaling pathways.

Indexed as

AtherosclerosisEndothelial damageInflammatory responsePoecilobdella manillensis

Identifiers

PMID41503135
PMCPMC12768939

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.